s,n,n'-tripropylthiocarbamate and Wasting Disease

s,n,n'-tripropylthiocarbamate has been researched along with Wasting Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Docherty, NG; Elliott, JA; Goldstone, AP; Healy, ML; le Roux, CW; McMorrow, JP; Moran, B; Murphy, CF; Ravi, N; Reynolds, JV; Stratford, N	1

Trials

1 trial(s) available for s,n,n'-tripropylthiocarbamate and Wasting Disease

Article	Year
A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy. The Journal of clinical endocrinology and metabolism, 2021, 01-01, Volume: 106, Issue:1 Topics: Adenocarcinoma; Aged; Brain; Delayed-Action Preparations; Esophageal Neoplasms; Esophagectomy; Feasibility Studies; Female; Gastrointestinal Hormones; Gastrointestinal Tract; Humans; Male; Middle Aged; Octreotide; Pilot Projects; Postoperative Complications; Postprandial Period; Reward; Satiety Response; Signal Transduction; Wasting Syndrome; Weight Loss	2021

Article

Year

A Pilot Study of Gut-Brain Signaling After Octreotide Therapy for Unintentional Weight Loss After Esophagectomy.

The Journal of clinical endocrinology and metabolism, 2021, 01-01, Volume: 106, Issue:1

Topics: Adenocarcinoma; Aged; Brain; Delayed-Action Preparations; Esophageal Neoplasms; Esophagectomy; Feasibility Studies; Female; Gastrointestinal Hormones; Gastrointestinal Tract; Humans; Male; Middle Aged; Octreotide; Pilot Projects; Postoperative Complications; Postprandial Period; Reward; Satiety Response; Signal Transduction; Wasting Syndrome; Weight Loss

2021